HC Surgical Specialists Limited (SGX:1B1)

Market Cap	50.61M -2.9%
Revenue (ttm)	19.73M +2.2%
Net Income	6.98M -17.2%
EPS	0.05 -17.1%
Shares Out	153.38M
PE Ratio	7.25
Forward PE	n/a
Dividend	0.02 (6.30%)
Ex-Dividend Date	Mar 2, 2026

Volume	184,300
Open	0.3400
Previous Close	n/a
Day's Range	0.3300 - 0.3450
52-Week Range	0.3250 - 0.4000
Beta	-0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 5, 2026

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2015
• Employees: 18
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 1B1

Financial Performance

In fiscal year 2026, HC Surgical Specialists's revenue was 19.73 million, an increase of 2.22% compared to the previous year's 19.30 million. Earnings were 6.98 million, a decrease of -17.24%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 16, 2026

Data Sources Report a data error